Application of whole‐lesion histogram analysis of pharmacokinetic parameters in dynamic contrast‐enhanced MRI of breast lesions with the CAIPIRINHA‐Dixon‐TWIST‐VIBE technique. Issue 1 (3rd June 2017)
- Record Type:
- Journal Article
- Title:
- Application of whole‐lesion histogram analysis of pharmacokinetic parameters in dynamic contrast‐enhanced MRI of breast lesions with the CAIPIRINHA‐Dixon‐TWIST‐VIBE technique. Issue 1 (3rd June 2017)
- Main Title:
- Application of whole‐lesion histogram analysis of pharmacokinetic parameters in dynamic contrast‐enhanced MRI of breast lesions with the CAIPIRINHA‐Dixon‐TWIST‐VIBE technique
- Authors:
- Li, Zhiwei
Ai, Tao
Hu, Yiqi
Yan, Xu
Nickel, Marcel Dominik
Xu, Xiao
Xia, Liming - Abstract:
- Abstract : Purpose: To investigate the application of whole‐lesion histogram analysis of pharmacokinetic parameters for differentiating malignant from benign breast lesions on dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI). Materials and Methods: In all, 92 women with 97 breast lesions (26 benign and 71 malignant lesions) were enrolled in this study. Patients underwent dynamic breast MRI at 3T using a prototypical CAIPIRINHA‐Dixon‐TWIST‐VIBE (CDT‐VIBE) sequence and a subsequent surgery or biopsy. Inflow rate of the agent between plasma and interstitium ( K trans ), outflow rate of agent between interstitium and plasma ( K ep ), extravascular space volume per unit volume of tissue ( v e ) including mean value, 25th/50th/75th/90th percentiles, skewness, and kurtosis were then calculated based on the whole lesion. A single‐sample Kolmogorov–Smirnov test, paired t ‐test, and receiver operating characteristic curve (ROC) analysis were used for statistical analysis. Results: Malignant breast lesions had significantly higher K trans, K ep, and lower v e in mean values, 25th/50th/75th/90th percentiles, and significantly higher skewness of v e than benign breast lesions (all P < 0.05). There was no significant difference in kurtosis values between malignant and benign breast lesions (all P > 0.05). The 90th percentile of K trans, the 90th percentile of K ep, and the 50th percentile of v e showed the greatest areas under the ROC curve (AUC) for each pharmacokineticAbstract : Purpose: To investigate the application of whole‐lesion histogram analysis of pharmacokinetic parameters for differentiating malignant from benign breast lesions on dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI). Materials and Methods: In all, 92 women with 97 breast lesions (26 benign and 71 malignant lesions) were enrolled in this study. Patients underwent dynamic breast MRI at 3T using a prototypical CAIPIRINHA‐Dixon‐TWIST‐VIBE (CDT‐VIBE) sequence and a subsequent surgery or biopsy. Inflow rate of the agent between plasma and interstitium ( K trans ), outflow rate of agent between interstitium and plasma ( K ep ), extravascular space volume per unit volume of tissue ( v e ) including mean value, 25th/50th/75th/90th percentiles, skewness, and kurtosis were then calculated based on the whole lesion. A single‐sample Kolmogorov–Smirnov test, paired t ‐test, and receiver operating characteristic curve (ROC) analysis were used for statistical analysis. Results: Malignant breast lesions had significantly higher K trans, K ep, and lower v e in mean values, 25th/50th/75th/90th percentiles, and significantly higher skewness of v e than benign breast lesions (all P < 0.05). There was no significant difference in kurtosis values between malignant and benign breast lesions (all P > 0.05). The 90th percentile of K trans, the 90th percentile of K ep, and the 50th percentile of v e showed the greatest areas under the ROC curve (AUC) for each pharmacokinetic parameter derived from DCE‐MRI. The 90th percentile of K ep achieved the highest AUC value (0.927) among all histogram‐derived values. Conclusion: The whole‐lesion histogram analysis of pharmacokinetic parameters can improve the diagnostic accuracy of breast DCE‐MRI with the CDT‐VIBE technique. The 90th percentile of K ep may be the best indicator in differentiation between malignant and benign breast lesions. Level of Evidence: 4 Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2018;47:91–96. … (more)
- Is Part Of:
- Journal of magnetic resonance imaging. Volume 47:Issue 1(2018)
- Journal:
- Journal of magnetic resonance imaging
- Issue:
- Volume 47:Issue 1(2018)
- Issue Display:
- Volume 47, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 47
- Issue:
- 1
- Issue Sort Value:
- 2018-0047-0001-0000
- Page Start:
- 91
- Page End:
- 96
- Publication Date:
- 2017-06-03
- Subjects:
- contrast‐enhanced MR -- pharmacokinetic parameters -- histogram analysis -- quantitative imaging -- breast lesions
Magnetic resonance imaging -- Periodicals
616 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1522-2586 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/jmri.25762 ↗
- Languages:
- English
- ISSNs:
- 1053-1807
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5010.791000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8731.xml